Download Items for Appendix

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
NCCN Chemotherapy Order Templates
Appendix B
Appendix B: Carboplatin Dosing
Cockcroft-Gault Equation1

Substitute GFR with creatinine clearance that is calculated via Cockcroft-Gault equation
CrCl Calculation (Cockroft-Gault Formula):
CrCl (men; mL/min) = (140 – age) x (weight in kg) ÷ (serum creatinine [mg/dL] x 72)
CrCl (women; mL/min) = 0.85 x CrCl (men)
Isotope Dilution Mass Spectrometry (IDMS)


Utilizes standardized method to measure serum creatinine (SCr) utilized by US clinical
laboratories2
May underestimate SCr values compared to older methods when the SCr values are
relatively low
Calvert Equation3

Calvert equation: Dose (mg) = Target AUC x (glomerular filtration rate [GFR]* + 25)
*GFR estimated by calculated creatinine clearance.
Maximum Carboplatin Dose Calculation2


The FDA has recommended a maximum creatinine clearance (CrCl) for use in
calculating carboplatin doses to minimize toxicity. The maximum dose is based on a GFR
estimate that is capped at 125 ml/min for patients with normal renal function.
If the carboplatin dose is calculated utilizing the IDMS-derived CrCl (GFR) within the
Calvert equation, carboplatin dosing could be higher than desired, and could result in
increased drug-related toxicities.
Maximum Carboplatin Dose (mg) = Target AUC (mg∙min/mL) x (150 mL/min)
© 2011 National Comprehensive Cancer Network
1
REFERENCE
1. Cockcroft DW, Gault MH. Nephron. 1976;16(1):31-41.
2. FDA Center for Drug Evaluation and Research. Carboplatin dosing.
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm228974.htm. October 8, 2010.
Accessed April 15, 2011.
3. Calvert AH, Newell DR, Gumbrell LA, et al. J Clin Oncol. 1989;7(11):1748-56
© 2011 National Comprehensive Cancer Network
2
Related documents